Research study Program year 2020 Source: CMS Open Payments

M14-465

ClinicalTrials.gov NCT02629159

Research payments

$3,200,372

1,402 payments

Through program year 2020, $3,200,372 in research payments was reported against M14-465, across 1,402 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT02629159

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$1,366,771	696
2019	Research	$1,833,601	706

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $3,200,372 1,402 payments

Who received the money Research payments · program years 2019–2020

Spire Sciences INC Organisation paid for research $682,500 13 payments
Dynamed Clinical Research LP Organisation paid for research $300,180 74 payments
Lakes Research LLC Organisation paid for research $180,540 108 payments
Interspond Llc Organisation paid for research $104,477 67 payments
Djl Clinical Research Pllc Organisation paid for research $93,282 50 payments
Accurate Clinical Research INC Organisation paid for research $91,824 100 payments
Biovin Enterprises LLC Organisation paid for research $70,052 22 payments
Rheumatology Diseases Treatment Center Organisation paid for research $61,182 33 payments
Desert Medical Advances Organisation paid for research $60,645 29 payments
Southwest Rheumatology Research LLC Organisation paid for research $59,666 21 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.